期刊
EXPERT OPINION ON DRUG DELIVERY
卷 13, 期 8, 页码 1149-1163出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/17425247.2016.1178235
关键词
Chemoenzymatic conjugation; diabody; molecular imaging; nanobody; scFv; sdAb; site-specific labeling
资金
- PhD fellowship of the Research Foundation - Flanders (FWO)
- Wetenschappelijk Fonds Willy Gepts of UZ Brussel
- Research Foundation - Flanders (FWO) [G066615N]
Introduction: Radioimmunotracers are a promising class of companion diagnostics for precision medicine. They are composed of an antibody-based targeting agent and a radiolabeled imaging probe. Together with the tendency towards the use of small antibody-derived fragments, the employed conjugation method is gaining increasing attention. Conventional bioconjugation methods result in heterogeneous tracer populations of which the single elements can differ in immunoreactivity, pharmacokinetic behavior and stability. Site-specific conjugation strategies try to overcome these shortcomings and facilitate radioimmunotracer delivery, characterization and manufacturing. Areas covered: An overview is provided of site-specific conjugation strategies for use in radioimmunotracer development. Currently applied strategies are discussed, together with other emerging site-specific conjugation methods that are applicable to diabodies, single-chain variable fragments (scFvs) and camelid single-domain antibody-fragments (sdAbs or nanobodies). Expert opinion: The ultimate goal of site-specific bioconjugation strategies is to allow precise control over the conjugation site, to result in homogenous tracer populations, and to be versatile in use with different imaging probes. Chemoenzymatic methods appear to be promising in this respect.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据